{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:13:01Z","timestamp":1700179981104},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>We aimed to determine the time interval between alfentanil and rocuronium administration, at a 50% probability of preventing pain-induced withdrawal movement from rocuronium injection (Time<jats:sub>AR<\/jats:sub>50).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 64 patients scheduled for general anesthesia were enrolled in this study (33 men and 31 women). Anesthesia was induced with target-controlled infusion of propofol, at an effect-site target concentration of 3\u2009\u03bcg\/mL. Then, alfentanil 15\u2009\u03bcg\/kg was injected for 30\u2009s. After 60\u2009s, rocuronium 0.6\u2009mg\/kg was administered to the first patient. The Dixon\u2019s up-and-down method was used to determine the time interval for each subsequent patient (interval of 5\u2009s). Mean arterial pressure (MAP) and heart rate (HR) were recorded at three time points: T0, pre-induction; T1, before rocuronium injection; and T2, 1\u2009min after rocuronium injection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Time<jats:sub>AR<\/jats:sub>50\u2009\u00b1\u2009standard deviation (SD) was 5.6\u2009\u00b1\u20093.7\u2009s and 21.9\u2009\u00b1\u20095.6\u2009s in the male and female patients, respectively. Based on the probit regression, the Time<jats:sub>AR<\/jats:sub>50 was 4.7\u2009s (95% confidence interval [CI], 1.2\u20137.6\u2009s) and 20.3\u2009s (95% CI, 7.7\u201326.1\u2009s) in the male and female patients, respectively. The Time<jats:sub>AR<\/jats:sub>95 was 10.6\u2009s (95% CI, 7.7\u201325.3\u2009s) and 35.0\u2009s (95% CI, 28.1\u201395.5\u2009s) in the male and female patients, respectively, with significantly higher values in females than in males (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Compared with the T0, MAP and HR decreased significantly at T1 and T2 in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The Time<jats:sub>AR<\/jats:sub>50 required for preventing rocuronium-induced withdrawal movement were 4.7\u2009s and 20.3\u2009s in male and female patients, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>This study was registered with the Chinese Clinical Trials Registry on April 7, 2021 (URL:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">http:\/\/www.chictr.org.cn<\/jats:ext-link>. Registry number:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=124491\">ChiCTR2100045137<\/jats:ext-link>) .<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12871-022-01580-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T07:03:14Z","timestamp":1643698994000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time interval between alfentanil and rocuronium administration necessary to prevent rocuronium-induced withdrawal movement"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiao-Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Lian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-tao","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Cang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"1580_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1213\/00000539-199607000-00065","volume":"83","author":"MA Steegers","year":"1996","unstructured":"Steegers MA, Robertson EN. Pain on injection of rocuronium bromide. Anesth Analg. 1996;83:193\u2013205.","journal-title":"Anesth Analg"},{"key":"1580_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1034\/j.1399-6576.2001.450813.x","volume":"45","author":"T Mencke","year":"2001","unstructured":"Mencke T, Beerhalter U, Fuchs-Buder T. Spontaneous movements, local reactions and pain on injection of rocuronium. A comparison between female and male patients. Acta Anaesthesiol Scand. 2001;45:1002\u20135.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1580_CR3","first-page":"617","volume":"25","author":"JT Lui","year":"2002","unstructured":"Lui JT, Huang SJ, Yang CY, Hsu JC, Lui PW. Rocuronium-induced generalized spontaneous movements cause pulmonary aspiration. Chang Gung Med J. 2002;25:617\u201320.","journal-title":"Chang Gung Med J"},{"key":"1580_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0310057X0303100306","volume":"31","author":"A Turan","year":"2003","unstructured":"Turan A, Memis D, Karamanlioglu B, Sut N, Pamukcu Z. The prevention of pain from injection of rocuronium by magnesium sulphate, lignocaine, sodium bicarbonate and alfentanil. Anaesth Intensive Care. 2003;31:277\u201381.","journal-title":"Anaesth Intensive Care"},{"key":"1580_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kjae.2013.64.1.25","volume":"64","author":"Y Jeon","year":"2013","unstructured":"Jeon Y, Ha JH, Lee JE, Lee HC, Ryu T, Kwak KH. Rocuronium-induced withdrawal movement: influence of ketorolac or a combination of lidocaine and ketorolac pretreatment. Korean J Anesthesiol. 2013;64:25\u20138.","journal-title":"Korean J Anesthesiol"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4097\/kjae.2014.67.3.175","volume":"67","author":"KT Jung","year":"2014","unstructured":"Jung KT, Kim HJ, Bae HS, Lee HY, Kim SH, So KY, et al. Effects of lidocaine, ketamine, and remifentanil on withdrawal response of rocuronium. Korean J Anesthesiol. 2014;67:175\u201380.","journal-title":"Korean J Anesthesiol"},{"key":"1580_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jclinane.2005.12.001","volume":"18","author":"KS Kim","year":"2006","unstructured":"Kim KS, Kim YS, Jeon WJ, Yeom JH. Prevention of withdrawal associated with the injection of rocuronium in adults and children. J Clin Anesth. 2006;18:334\u20138.","journal-title":"J Clin Anesth"},{"key":"1580_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jclinane.2008.06.016","volume":"21","author":"JH Kim","year":"2009","unstructured":"Kim JH, Kim JH, Han SH, Hwang JW, Oh AY. Alfentanil is comparable to remifentanil in preventing withdrawal movement following rocuronium injection. J Clin Anesth. 2009;21:9\u201312.","journal-title":"J Clin Anesth"},{"key":"1580_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0149-7634(05)80090-9","volume":"15","author":"WJ Dixon","year":"1991","unstructured":"Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15:47\u201350.","journal-title":"Neurosci Biobehav Rev"},{"key":"1580_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1213\/01.ANE.0000130005.94395.B2","volume":"99","author":"B Tuncali","year":"2004","unstructured":"Tuncali B, Karci A, Tuncali BE, Mavioglu O, Olguner CG, Ayhan S, et al. Dilution of rocuronium to 0.5 mg\/ml with 0.9% NaCl eliminates the pain during intravenous injection in awake patients. Anesth Analg. 2004;99:740\u20133.","journal-title":"Anesth Analg"},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00540-020-02889-2","volume":"35","author":"K Hamada","year":"2021","unstructured":"Hamada K, Takahashi K, Tokinaga Y, Iwasaki S, Yamakage M. Generic rocuronium reduces withdrawal movements compared to original rocuronium under target-controlled infusion induction with propofol. J Anesth. 2021;35:184\u20138.","journal-title":"J Anesth"},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1399-6576.2010.02317.x","volume":"55","author":"SH Park","year":"2011","unstructured":"Park SH, Oh AY, Goo EK, Nahm FS, Min SW, Hwang JW, et al. A short period of inhalation induction with sevoflurane prevents rocuronium-induced withdrawal in children. Acta Anaesthesiol Scand. 2011;55:87\u201391.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1580_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00540-014-1836-4","volume":"28","author":"SA Abu-Halaweh","year":"2014","unstructured":"Abu-Halaweh SA, Aloweidi AK, Qudaisat IY, AI-Hussami MO, Al Zaben KR, Abu-Halaweh AS. Pretreatment with remifentanil, fentanyl, or lidocaine to prevent withdrawal after rocuronium using venous occlusion technique in children and adolescents: a prospective randomized placebo-controlled double-blind study. J Anesth. 2014;28:886\u201390.","journal-title":"J Anesth"},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1213\/01.ANE.0000147790.76114.3A","volume":"100","author":"N Ahmad","year":"2005","unstructured":"Ahmad N, Choy CY, Aris EA, Balan S. Preventing the withdrawal response associated with rocuronium injection: a comparison of fentanyl with lidocaine. Anesth Analg. 2005;100:987\u201390.","journal-title":"Anesth Analg"},{"key":"1580_CR15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1399-6576.2007.01371.x","volume":"51","author":"AY Oh","year":"2007","unstructured":"Oh AY, Seo KS, Goo EK, Park YO, Kim SJ, Kim JH. Prevention of withdrawal movement associated with injection of rocuronium in children: comparison of remifentanil, alfentanil and fentanyl. Acta Anaesthesiol Scand. 2007;51:1190\u20133.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1580_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1460-9592.2008.02558.x","volume":"18","author":"JY Kim","year":"2008","unstructured":"Kim JY, Kwak HJ, Kim JY, Park KS, Song JS. Prevention of rocuronium-induced withdrawal movement in children: a comparison of remifentanil with alfentanil. Paediatr Anaesth. 2008;18:245\u201350.","journal-title":"Paediatr Anaesth"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01580-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01580-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01580-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:52:37Z","timestamp":1700153557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01580-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01580-1","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Medical Ethics Committee of Taizhou hospital of Zhejiang Province, Taizhou, Zhejiang, China (Ethical number: K20201230). All methods were performed in accordance with the relevant guidelines and regulations. The study was registered with the Chinese Clinical Trials Registry on April 7, 2021 (URL:ExternalRef removed. Registry number: ChiCTR2100045137). All patients provided consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}